MyMD Pharmaceuticals News

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 61% of MyMD Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in MyMD Pharmaceuticals suggests that many traders are alarmed regarding MyMD Pharmaceuticals' prospects. The current market sentiment, together with MyMD Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use MyMD Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at businesswire.com         
MyMD Pharmaceuticals Secures Strategic Investments
businesswire News
over six months ago at seekingalpha.com         
PharmaCyte Biotech announces 7 million strategic investment in MYMD
seekingalpha News
over six months ago at investorplace.com         
MYMD Stock Earnings MyMD Pharmaceuticals Reported Results for Q4 2023
sbwire news
over six months ago at news.google.com         
Is MyMD Pharmaceuticals, Inc. Popular Amongst Insiders - Yahoo Lifestyle Australia
Google News at Macroaxis
over six months ago at news.google.com         
Why Is Vincerx Pharma Stock Down 64 percent Today - MSN
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Silverman Joshua of 5201 shares of MyMD Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over six months ago at investorplace.com         
Why Is MyMD Pharmaceuticals Stock Up 35 percent Today?
sbwire news
over six months ago at investorplace.com         
Why Is Vivos Therapeutics Stock Up 16 percent Today?
sbwire news
over six months ago at news.google.com         
MyMD Pharmaceuticals Enhances Governance and Financing Structure - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
MyMD Pharmaceuticals Begins Trading on Nasdaq - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
MyMD Pharmaceuticals Stock Price Up 1.7 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Is MyMD Pharmaceuticals Inc Stock a Smart Value - InvestorsObserver
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Silverman Joshua of 200000 shares of MyMD Pharmaceuticals at 1.66 subject to Rule 16b...
Macroaxis News
over six months ago at news.google.com         
MyMD Pharmaceuticals Trading 3.3 percent Higher - Defense World
Google News at Macroaxis
over six months ago at seekingalpha.com         
MyMD Pharmaceuticals said it has regained compliance with Nasdaq rules
seekingalpha News
Far too much social signal, news, headlines, and media speculation about MyMD Pharmaceuticals that are available to investors today. That information is available publicly through MyMD media outlets and privately through word of mouth or via MyMD internal channels. However, regardless of the origin, that massive amount of MyMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MyMD Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MyMD Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MyMD Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MyMD Pharmaceuticals alpha.

MyMD Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
PharmaCyte Biotech Makes 7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
05/21/2024
2
Disposition of 3854626 shares by Pharmacyte Biotech, Inc. of MyMD Pharmaceuticals at 1.816 subject to Rule 16b-3
05/23/2024
3
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
06/17/2024
4
MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.
07/22/2024
5
TNF Pharmaceuticals Begins Trading Under New Nasdaq Stock Symbol TNFA Effective Before Market Open Today - StockTitan
07/24/2024
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges